These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35850688)

  • 1. Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes.
    Ferreira-Divino LF; Suvitaival T; Rotbain Curovic V; Tofte N; Trošt K; Mattila IM; Theilade S; Winther SA; Hansen TW; Frimodt-Møller M; Legido-Quigley C; Rossing P
    Cardiovasc Diabetol; 2022 Jul; 21(1):135. PubMed ID: 35850688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes.
    Tofte N; Suvitaival T; Ahonen L; Winther SA; Theilade S; Frimodt-Møller M; Ahluwalia TS; Rossing P
    Sci Rep; 2019 Nov; 9(1):16398. PubMed ID: 31705008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes.
    Sharif S; van der Graaf Y; Nathoe HM; de Valk HW; Visseren FL; Westerink J;
    Diabetes Care; 2016 Aug; 39(8):1424-30. PubMed ID: 27222511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
    Cavus E; Karakas M; Ojeda FM; Kontto J; Veronesi G; Ferrario MM; Linneberg A; Jørgensen T; Meisinger C; Thorand B; Iacoviello L; Börnigen D; Woodward M; Schnabel R; Costanzo S; Tunstall-Pedoe H; Koenig W; Kuulasmaa K; Salomaa V; Blankenberg S; Zeller T;
    JAMA Cardiol; 2019 Dec; 4(12):1270-1279. PubMed ID: 31664431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
    Al-Shamsi S; Regmi D; Govender RD
    BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of Diabetic Retinopathy and the Risk of Future Cerebrovascular Disease, Cardiovascular Disease, and All-Cause Mortality.
    Modjtahedi BS; Wu J; Luong TQ; Gandhi NK; Fong DS; Chen W
    Ophthalmology; 2021 Aug; 128(8):1169-1179. PubMed ID: 33359888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carotid-Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus.
    Tougaard NH; Theilade S; Winther SA; Tofte N; Ahluwalia TS; Hansen TW; Rossing P; Frimodt-Møller M
    J Am Heart Assoc; 2020 Oct; 9(19):e017165. PubMed ID: 32955366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.
    Wan EYF; Fung CSC; Yu EYT; Chin WY; Fong DYT; Chan AKC; Lam CLK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Effects of Fasting Glucose, Hemoglobin A
    Su WY; Chen SC; Huang YT; Huang JC; Wu PY; Hsu WH; Lee MY
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in cardiovascular risk factors of children and adolescents with type 1 diabetes mellitus: A role for diet?
    Maffeis C; Olivieri F; Peverelli P; Cendon M; Tomasselli F; Tommasi M; Trandev T; Fornari E; Piona C; Morandi A; Maguolo A
    Nutr Metab Cardiovasc Dis; 2022 Apr; 32(4):1045-1054. PubMed ID: 35086767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GREATER LOW-DENSITY LIPOPROTEIN CHOLESTEROL VARIABILITY INCREASES THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.
    Hsu WH; Lai CW; Chen SC; Chiou HC; Hsiao PJ; Shin SJ; Lee MY
    Endocr Pract; 2019 Sep; 25(9):918-925. PubMed ID: 31070951
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in the lipidome in type 1 diabetes following low carbohydrate diet: Post-hoc analysis of a randomized crossover trial.
    Al-Sari N; Schmidt S; Suvitaival T; Kim M; Trošt K; Ranjan AG; Christensen MB; Overgaard AJ; Pociot F; Nørgaard K; Legido-Quigley C
    Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00213. PubMed ID: 33855215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of circulating metabolites to an oral glucose challenge and risk of cardiovascular disease and mortality in the community.
    Gonzalez Izundegui D; Miller PE; Shah RV; Clish CB; Walker ME; Mitchell GF; Gerszten RE; Larson MG; Vasan RS; Nayor M
    Cardiovasc Diabetol; 2022 Oct; 21(1):213. PubMed ID: 36243866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of soluble tumor necrosis factor receptors 1 and 2 with nephropathy, cardiovascular events, and total mortality in type 2 diabetes.
    Carlsson AC; Östgren CJ; Nystrom FH; Länne T; Jennersjö P; Larsson A; Ärnlöv J
    Cardiovasc Diabetol; 2016 Feb; 15():40. PubMed ID: 26928194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The metabolic syndrome in patients with type 1 diabetes mellitus. Associations with cardiovascular risk factors and cardiovascular morbidity].
    Reindel J; Zander E; Heinke P; Kohnert KD; Allwardt C; Kerner W
    Herz; 2004 Aug; 29(5):463-9. PubMed ID: 15340731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visit-to-visit variability of clinical risk markers in relation to long-term complications in type 1 diabetes.
    Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Tarnow L; Jorsal A; Parving HH; Persson F; Hansen TW; Rossing P
    Diabet Med; 2021 May; 38(5):e14459. PubMed ID: 33179275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA).
    Pease A; Earnest A; Ranasinha S; Nanayakkara N; Liew D; Wischer N; Andrikopoulos S; Zoungas S
    Cardiovasc Diabetol; 2018 Jun; 17(1):77. PubMed ID: 29859534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple risk factor control, mortality and cardiovascular events in type 2 diabetes and chronic kidney disease: a population-based cohort study.
    Hamada S; Gulliford MC
    BMJ Open; 2018 May; 8(5):e019950. PubMed ID: 29739781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.